DYAMTWVR* – SIL Dupilumab signature peptide qualifier

DYAMTWVR Stable Isotope Labeled Infliximab (DPL) peptide serves as a secondary internal standard to confirm DPL’s presence in biological samples by mass spectrometry.

SB-PEPTIDE’s Dupilumab SIL signature peptide qualifier is designed and optimized to provide the best mass spectrometry performance during your Mass Spec assay. It is used in combination with Dupilumab SIL peptide quantifier,that is used as primary internal standard for DPL detection and quantification.

Technical specification

Price